Skip to content
Open access

Genetic Associations with Alzheimer's, Lewy Body and Vascular Neuropathology Reveal Shared and Distinct Biological Pathways

Sep 2026 · medRxiv · 0 citations
Medicine

TL;DR

Different neuropathological outcomes appear to be driven by distinct genetic variants but converge on shared genes and biological processes related to neuronal structure and communication, as revealed in Alzheimers neuropathology.

Read PDF

Similar papers

Open access Sep 2026

Elucidating shared genetic signals between type 2 diabetes and three neurodegenerative dementia phenotypes

These findings identify shared genetic loci between T2D and neurodegenerative dementia, revealing systemic metabolic-neurodegenerative trade-offs and highlighting key genes that underpin the comorbidity, providing a framework for improved understanding of age-related multi-morbidity.

A. Arruda, Archit Singh, O. Bocher et al. · 0 citations
Open access Sep 2026

Stratifying Alzheimer’s disease by patient-specific genetic signatures reveals cognition-linked and cross-disease heterogeneity

A heteroscedastic personalized regression framework is introduced to move beyond cohort-averaged associations and construct individualized single-nucleotide polymorphism (SNP) profiles for each subject, showing that model-derived individualized SNP-score profiles can reveal latent structure associated with cognitive an...

Jia-Hui Zhang, Zi-Yu Yu, Xing-Cai Zhang et al. · 0 citations
Open access Oct 2026

Mapping polygenic risk scores to brain cells: insights for neurodegenerative diseases

Neurodegenerative diseases (NDDs) are driven by multiple related yet distinct pathological processes that evolve over decades, resulting in substantial clinical and neuropathological heterogeneity. Postmortem examinations of older individuals frequently reveal multiple coexisting neuropathologies, however, the underlyi...

E. Simmonds, A. Mckeever, U. Yaman et al. · 0 citations
Open access Sep 2026

Data-driven subtypes of Alzheimer’s Disease: A multicohort study

These findings, replicated in four diverse and independent datasets, support imaging-based subtyping as a scalable and clinically translatable approach for capturing heterogeneity in AD pathophysiology and associated cognitive trajectories.

A. Metz, Cassandra Polizzi, R. Moqadam et al. · 0 citations
Review Sep 2026

Atypical Alzheimer disease: a multi-axis framework toward defining heterogeneity.

A practical multi-axis framework comprising clinical phenotype, AD biological context (AD pathology plus co-pathologies and molecular modifiers), network topography (regional patterns) and tempo (rate of clinical and biomarker progression) is proposed to reduce diagnostic mismatches, make cohorts more comparable and su...

L. Grinberg, M. Murray · 0 citations
Open access Sep 2026

GWAS of Tau‐Neurodegeneration Mismatch Identifies New Risk Loci for Susceptibility to Tau

A genome‐wide association study of tau‐related neurodegeneration identified two novel genetic variants in the loci AKAP9 and STXBP6 leading to higher than expected regional neurodegeneration given the tau level.

F. Nabizadeh, Hanieh Mohamadi · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.